Jean‐François Claisse

Evaluation of Residual Disease in B-Cell Chronic Lymphocytic Leukemia Patients in Clinical and Bone-Marrow Remission Using CD5-CD19 Markers and PCR Study of Gene Rearrangements

Françoise Vuillier, Jean‐François Claisse, C. Vandenvelde et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1992 · 52 citations

CD66c expression in B‐cell acute lymphoblastic leukemia: strength and weakness

Nicolas Guillaume, Dominique Penther, Ioana Vaida et al. · International Journal of Laboratory Hematology · 2010 · 27 citations

Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases

Mathieu Leclerc, Felipe Suárez, Marie‐Pierre Noël et al. · Annals of Hematology · 2014 · 26 citations · Full text

Retrospective Study, Lymphoid Neoplasia, Hematological Malignancy +8

Long‐term clinical outcome of B‐cell chronic lymphocytic leukaemia patients in clinical remission phase evaluated at phenotypic level

Maura Brugiatelli, Jean‐François Claisse, Bernard Lenormand et al. · British Journal of Haematology · 1997 · 24 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Normalized Phenotype +14

TLR9 Ligand (CpG Oligodeoxynucleotide) Induces CLL B-Cells to Differentiate into CD20+ Antibody-Secreting Cells

Hussein Ghamlouch, Hakim Ouled‐Haddou, Aude Guyart et al. · Frontiers in Immunology · 2014 · 17 citations · Full text